{
  "docId": "019de073-cc15-73cb-b985-dc28972c4284",
  "docSlug": "df7f4367d54f16f4cdacd02ff486e30b",
  "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
  "authorId": "matinas-biopharma",
  "authorName": "Matinas BioPharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 23,
  "pageCount": 31,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The slide uses a map of the US to anchor the revenue projection and a list of four comparable deals to establish market precedent.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-cc15-73cb-b985-dc28972c4284/23",
  "deckHref": "/decks/019de073-cc15-73cb-b985-dc28972c4284",
  "deckJsonHref": "/decks/019de073-cc15-73cb-b985-dc28972c4284.json",
  "deckAnchorHref": "/decks/019de073-cc15-73cb-b985-dc28972c4284#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.42,
        "x": 0.04,
        "y": 0.215
      },
      "kind": "image",
      "text": "US Map",
      "attrs": null,
      "subkind": "map",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0c12a29e-9984-49d8-88f9-04af0f22cf74",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.42,
        "x": 0.04,
        "y": 0.7
      },
      "kind": "list",
      "text": "Cryptococcal Meningitis; Invasive fungal infections; Prophylaxis in IC patients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e5416645-e455-40f4-a4b3-d752d9ee4439",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.38,
        "x": 0.06,
        "y": 0.33
      },
      "kind": "paragraph",
      "text": "MAT2203 Planned LCM expected to reach $500M-$750M in US Revenue",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a20e068-3da3-4584-af66-20d85d178c29",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.48,
        "x": 0.48,
        "y": 0.16
      },
      "kind": "table",
      "text": "Comparable Deals: Cidara/Mundipharma, Scynexis/Hansoh, F2G/Shionogi, Cidara/Melinta",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b46710d2-1d2d-4086-a01a-9398287bdbc1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.92,
        "x": 0.04,
        "y": 0.07
      },
      "kind": "title",
      "text": "MAT2203: Addressing a $550M+ Market with Active Regional and Global Pharma",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "640f529e-7152-4812-801e-278f8ca30c7f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "ac59ab9c-ac27-4677-b542-fce412dd937e",
      "evidence": "title/headline: MAT2203: Addressing a $550M+ Market with Active Regional and Global Pharma",
      "confidence": 0.5
    },
    {
      "name": "Market Segmentation Pyramid",
      "slug": "market-segmentation-pyramid",
      "agent": null,
      "layer": "slide",
      "matchId": "c92b0791-d491-4ea3-893c-036354f60802",
      "evidence": "list/bullet: Cryptococcal Meningitis; Invasive fungal infections; Prophylaxis in IC patients",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "3b56bb4d-e45e-429e-b8cc-b821a09761e6",
      "evidence": "Using comparable deals to validate market valuation",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 23,
      "from": 23,
      "beatId": "9ce015ba-65f3-4cfd-a4c9-65b2cf21aa9f",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Sizing",
      "beatSlug": null,
      "evidence": "Slide 23 presents market sizing information for MAT2203",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}